“PROCAM Based Myocardial Infarction Risk in Relation to Global Vascular Disease Risk: Observations from the ARCO Cohort Study”. 2022. Swiss Medical Weekly 152 (0708): w30111. https://doi.org/10.4414/SMW.2022.w30111.